Today

Agents

Chat

Arena

Discover

More

App

Lenz Therapeutics reports third-quarter 2026 financial results - LENZ News | Rallies

Lenz Therapeutics reports third-quarter 2026 financial results

LENZ•2026-10-28

Lenz Therapeutics reported third-quarter 2026 financial results and announced a consumer-marketing-focused reorganization and CEO succession.

1. Results and reorganization

Lenz Therapeutics announced third-quarter 2026 financial results, a strategic reorganization focused on consumer marketing and a CEO succession.

Related News

Marvell reportedly in advanced talks to buy Lumentum

MRVL•2026-10-28

Encompass Health raises 2026 adjusted EPS outlook to $6.23-$6.37

EHC•2026-10-28

Milestone Pharmaceuticals receives Nasdaq noncompliance notice over minimum bid price

2026-10-28

Albany International swings to Q3 2026 net profit of $41.7 million; revenue rises 34% to $349.5 million

AIN•2026-10-28

Nvidia sets conference call for third-quarter financial results

NVDA•2026-10-28